Prostate Cancer
Zytiga® receives positive regulatory recommendation In the European Union for treatment of metastatic castration resistant prostate cancer
September 8, 2011
Factors predicting continence recovery 1 month after radical prostatectomy: Results of a multicenter survey - Abstract
September 7, 2011
Prognostic role of vitamin D status and efficacy of vitamin D supplementation in cancer patients: A systematic review - Abstract
September 7, 2011
The burden of depression in prostate cancer - Abstract
September 7, 2011
Can the prostate risk calculator based on the Western population be applied to the Asian population? - Abstract
September 7, 2011
Mapping the psychosocial and practical support needs of cancer patients in Western Australia - Abstract
September 7, 2011
Toward an optimal interval for prostate cancer screening - Abstract
September 7, 2011
Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading - Abstract
September 7, 2011
Models to predict positive prostate biopsies using the Tyrol screening study - Abstract
September 7, 2011
Editor's Commentary - Inhibition of Src family kinases and receptor tyrosine kinases by dasatinib: Possible combinations in solid tumors
September 7, 2011
Ethnic differences in prostate cancer - Abstract
September 6, 2011
DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer - Abstract
September 6, 2011
Recent advances in the therapy of castration-resistant prostate cancer: The price of progress - Abstract
September 6, 2011
Prospective study of extended versus limited lymphadenectomy in patients undergoing radical prostatectomy with localized prostate cancer - Abstract
September 6, 2011
Photoacoustic imaging of prostate brachytherapy seeds - Abstract
September 6, 2011